MktsMarkets

ADC Therapeutics SA
NYSE: ADCTKey statistics
ADCT News
Stories mentioning ADCT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 20,033 | 30,118 | 15,750 | 18,085 | 17,404 | 17,943 | 18,016 | 17,030 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 19,877 | 18,184 | 26,803 | 30,090 | 28,928 | 27,101 | 32,502 | 24,295 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (25,245) | (17,919) | (30,969) | (44,147) | (28,464) | (32,436) | (35,564) | (29,041) |
| Interest Income | 1,994 | 2,352 | 2,470 | 1,934 | 2,054 | 2,633 | 3,438 | 3,253 |
| Interest Expense | 12,230 | 11,919 | 13,117 | 12,679 | ||||
| Other Expense | 2,632 | 21,768 | 925.00 | (182.00) | 203.00 | 10,674 | 1,624 | 2,754 |
| Pretax Income | (32,968) | (38,437) | ||||||
| Tax Provision | 0.00 | (404.00) | 0.00 | 1,254 | 165.00 | (321.00) | 90.00 | 234.00 |
| Net Income (Loss) | (32,968) | (6,409) | (40,966) | (56,646) | (38,602) | (30,727) | (43,969) | (36,544) |
| Earnings Per Share (Basic) | (0.21) | (0.05) | (0.30) | (0.50) | (0.36) | (0.32) | (0.42) | (0.38) |
| Earnings Per Share (Diluted) | (0.21) | (0.05) | (0.30) | (0.50) | (0.36) | (0.32) | (0.42) | (0.38) |
| Weighted Average Shares Outstanding (Basic) | 154,142 | 127,068 | 136,447 | 113,743 | 107,202 | 97,160 | 104,825 | 95,691 |
| Weighted Average Shares Outstanding (Diluted) | 154,142 | 127,068 | 136,447 | 113,743 | 107,202 | 97,160 | 104,825 | 95,691 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ADCT
ADC Therapeutics SA (NYSE: ADCT) is a stock listed on the New York Stock Exchange under the ticker symbol ADCT. It last traded at $1.34 (Nov 13, 2026, 4:00 PM ET), down 5.0% on the day. That gives ADC Therapeutics a market capitalisation of $171.1M.
Over the past 52 weeks ADCT has traded between $0.7800 and $4.98.
Revenue for the quarter ended Mar 31, 2026 was $20.0M; a net loss of $33.0M. Revenue was up 15.1% from $17.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $20.0M | -$33.0M | -164.6% |
| Dec 31, 2025 | $30.1M | -$6.4M | -21.3% |
| Sep 30, 2025 | $15.8M | -$41.0M | -260.1% |
| Jun 30, 2025 | $18.1M | -$56.6M | -313.2% |
From ADC Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…